|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 31/593 | (2006.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61P 17/06 | (2006.01) |
| (11) | Number of the document | 3768241 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19709992.2 |
| Date of filing the European patent application | 2019-03-18 | |
| (97) | Date of publication of the European application | 2021-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (86) | Number | PCT/EP2019/056735 |
| Date | 2019-03-18 |
| (87) | Number | WO 2019/179958 |
| Date | 2019-09-26 |
| (30) | Number | Date | Country code |
| 18162664 | 2018-03-19 | EP |
| (72) |
CRUTCHLEY, Nigel , GB
GEORGIOU, Michelle , GB
LENON, Stephen , GB
PRAESTEGAARD, Morten , GB
|
| (73) |
MC2 Therapeutics Limited ,
James House
Emlyn Lane, Leatherhead
Surrey KT22 7EP,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vietinė kompozicija, apimanti kalcipotriolį ir betametazono dipropionatą |
| TOPICAL COMPOSITION COMPRISING CALCIPOTRIOL AND BETAMETHASONE DIPROPIONATE |
| Payment date | Validity (years) | Amount | |
| 2025-02-24 | 7 | 162.00 EUR |
| 2026-03-18 |